USD
What a Peptide Mass Match Can—and Cannot—Confirm
Short answer: a molecular-mass match can support that a measured analyte has a mass consistent with an expected peptide under the reported mass-spectrometry method. It does not, by itself, prove complete sequence, distinguish every isomer, quantify purity, or verify a particular catalog batch.
That is why a sound peptide record keeps molecular-mass evidence separate from purity, net-content, and batch-documentation claims. It answers one useful identity question, but not all of them. For the distinct evidence supplied by fragment patterns, compare intact-mass testing with peptide mapping.
What an intact-mass result compares
An intact-mass analysis compares an observed mass with an expected mass or a qualified reference. The comparison may be highly informative when the ion form, charge state, mass tolerance, sample preparation, and instrument conditions are stated. A close match supports consistency with the proposed molecular composition.
| Question | What a mass match may support | What it does not establish alone |
|---|---|---|
| Molecular mass | Consistency with the expected mass under the reported method. | Complete sequence confirmation. |
| Sample identity | Evidence that contributes to identity assessment. | That a catalog name, package, and tested sample are the same batch. |
| Sample quality | No direct purity conclusion. | Purity, potency, sterility, endotoxin status, or suitability. |
Why a mass match is not complete sequence proof
Different structures can sometimes share or closely approach the same nominal or exact mass. Sequence order, positional isomers, some modifications, and unresolved mixtures require an analytical strategy suited to the specific uncertainty. Fragment-ion data, peptide mapping, comparison with an appropriately characterized reference, and other orthogonal evidence may add information where needed.
The USP technical discussion of synthetic peptide reference standards describes mass spectrometry and chromatography as complementary parts of a wider analytical strategy, rather than a single all-purpose test. Read the USP technical paper for its method context.
A record-review checklist
- Match the report to the exact batch, product name, and listed size.
- Check whether the result is intact mass, fragment analysis, or another method.
- Read the observed value, expected value, tolerance, and reported ion form together.
- Keep molecular-mass evidence separate from any HPLC purity result.
- Record what remains untested instead of filling gaps with assumptions.
Keep molecular-mass evidence separate from the corresponding purity, content, and batch-documentation fields.
To apply this record-review workflow, start at the NOVABIO research catalog, browse GLP-based research peptides, then use the Retatrutide catalog page only to match its listed identity fields with any available batch record.
Limits of this guide
This article explains analytical-documentation concepts. It does not assess any NOVABIO batch, validate a laboratory, establish a product’s identity or quality, or provide human-use instructions.
Sources: USP technical paper on synthetic peptide reference standards. Products are listed for research, laboratory, or analytical use only.